Evidence map›Paper›PMID 35900020›Full record

ArticleProtein science : a publication of the Protein Society2022

Heterologous expression of naturally evolved putative de novo proteins with chaperones.

Lars A Eicholt, Margaux Aubel, Katrin Berk, Erich Bornberg-Bauer, Andreas Lange

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. The Functional Characteristics and Soluble Expression of SaffronInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. The permissive binding theory of cancer.Frontiers in oncology · 2023
    Article
  11. Review
  12. Heterologous expression of naturally evolved putative de novo proteins with chaperones.Protein science : a publication of the Protein Society · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lars A EicholtInstitute for Evolution and Biodiversity, University of Muenster, Münster, Germany.ORCID 0000-0002-3985-3698
Margaux AubelInstitute for Evolution and Biodiversity, University of Muenster, Münster, Germany.ORCID 0000-0003-1653-9441
Katrin BerkInstitute for Evolution and Biodiversity, University of Muenster, Münster, Germany.ORCID 0000-0002-8734-8047
Erich Bornberg-BauerInstitute for Evolution and Biodiversity, University of Muenster, Münster, Germany.ORCID 0000-0002-1826-3576
Andreas LangeInstitute for Evolution and Biodiversity, University of Muenster, Münster, Germany.ORCID 0000-0003-3871-1986

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past decade, evidence has accumulated that new protein-coding genes can emerge de novo from previously non-coding DNA. Most studies have focused on large scale computational predictions of de novo protein-coding genes across a wide range of organisms. In contrast, experimental data concerning the folding and function of de novo proteins are scarce. This might be due to difficulties in handling de novo proteins in vitro, as most are short and predicted to be disordered. Here, we propose a guideline for the effective expression of eukaryotic de novo proteins in Escherichia coli. We used 11 sequences from Drosophila melanogaster and 10 from Homo sapiens, that are predicted de novo proteins from former studies, for heterologous expression. The candidate de novo proteins have varying secondary structure and disorder content. Using multiple combinations of purification tags, E. coli expression strains, and chaperone systems, we were able to increase the number of solubly expressed putative de novo proteins from 30% to 62%. Our findings indicate that the best combination for expressing putative de novo proteins in E. coli is a GST-tag with T7 Express cells and co-expressed chaperones. We found that, overall, proteins with higher predicted disorder were easier to express. STATEMENT: Today, we know that proteins do not only evolve by duplication and divergence of existing proteins but also arise from previously non-coding DNA. These proteins are called de novo proteins. Their properties are still poorly understood and their experimental analysis faces major obstacles. Here, we aim to present a starting point for soluble expression of de novo proteins with the help of chaperones and thereby enable further characterization.

Indexed as

Drosophila melanogasterEscherichia coliAnimalsEukaryotic CellsMolecular ChaperonesProtein Structure, SecondaryMolecular Chaperoneschaperonesde novo proteindisorder and secondary structure predictionDrosophila melanogasterHomo sapiensWestern blot

Identifiers

PMID35900020
PMCPMC9278007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.